Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. (Q38195478)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

review article

1 reference

title

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

5

Rachel A Whitmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Geert Jan Biessels

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Mark W J Strachan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Jaap Kappelle

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

18 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

The Lancet: Diabetes & Endocrinology

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

246-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

Global prevalence of dementia: a Delphi consensus study

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Risk of dementia in diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Relation of diabetes to mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Accelerated progression from mild cognitive impairment to dementia in people with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Contribution of vascular risk factors to the progression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Cognitive dysfunction in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Cognition in the early stage of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Metabolic syndrome, cognitive performance, and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Metabolic syndrome and 16-year cognitive decline in community-dwelling older adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Longitudinal study of the transition from healthy aging to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Brain imaging in patients with diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Glycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes, hyperglycaemia, and acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Resting-state brain functional connectivity is altered in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

The projected effect of risk factor reduction on Alzheimer's disease prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Predictors of cognitive decline in older individuals with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Adiposity predicts cognitive decline in older persons with diabetes: a 2-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Predictors of cognitive impairment and dementia in older people with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Physical activity levels and cognition in women with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Dietary fat intake and cognitive decline in women with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Mild depressive symptoms do not influence cognitive functioning in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Epidemiology of depression and diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Risk factors for dementia in patients over 65 with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

1 reference

7 January 2021

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Human cerebral neuropathology of Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Amylin deposition in the brain: A second amyloid in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Islet amyloid polypeptide, islet amyloid, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Insulin in the brain: there and back again

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Glucocorticoids and the regulation of memory in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes--the ADDITION-Netherlands study: a cluster-randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970088-3

7 January 2021

10.1016/S2213-8587(13)70088-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622755%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference